Published in

Elsevier, Journal of Investigative Dermatology, 5(134), p. 1468-1470, 2014

DOI: 10.1038/jid.2013.378

Links

Tools

Export citation

Search in Google Scholar

Is a Single BRAF Wild-Type Test Sufficient to Exclude Melanoma Patients from Vemurafenib Therapy?

This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO